Chronic cough, defined as a cough persisting for more than eight weeks, poses a significant challenge in clinical practice due to its multifactorial etiology. This article aims to provide a comprehensive approach to diagnose and manage this common yet complex condition.
Chronic cough can be attributed to a variety of conditions such as gastroesophageal reflux disease (GERD), asthma, upper airway cough syndrome (UACS), and non-asthmatic eosinophilic bronchitis (NAEB). It is crucial to conduct a detailed clinical evaluation, including a thorough history and physical examination, to identify potential triggers and underlying conditions. Diagnostic tests such as spirometry, chest radiographs, and bronchoscopy can be used judiciously based on clinical suspicion.
Treatment of chronic cough should be tailored to the identified cause. For GERD-related cough, lifestyle modifications and proton pump inhibitors are first-line treatments. Inhaled corticosteroids are the treatment of choice for cough-variant asthma and NAEB, while UACS can be managed with first-generation antihistamines and nasal steroids. Empiric treatment trials can be considered when the etiology is unclear, but should be guided by the most likely diagnosis based on clinical features.
Despite a comprehensive approach, chronic cough remains a therapeutic challenge due to the lack of specific diagnostic markers and the potential for multiple concurrent etiologies. Future research should focus on identifying novel biomarkers and developing targeted therapies. It is also important to improve our understanding of the pathophysiology of chronic cough, which may lead to more effective treatment strategies.
In conclusion, chronic cough requires a meticulous, patient-centered approach for effective diagnosis and management. While several challenges persist, ongoing research and innovation hold promise for improving patient outcomes. Through a better understanding of the etiology and pathophysiology of chronic cough, clinicians can enhance their diagnostic acumen and therapeutic efficacy.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation